Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Stands to Pocket $25M in Private Stock Placement

NEW YORK, May 10 (GenomeWeb News) - Nanogen today said that it has received a commitment for up to $25 million in common stock equity financing from Azimuth Opportunity.

 

According to the agreement, over the next 18 months, Nanogen may sell registered shares of its common stock, at its discretion, to Azimuth Opportunity at a small discount from market price, the company said.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.